Human Genome Epidemiology Literature Finder
|
Records 1 - 16 (of 16 Records) |
| Query Trace: Carcinoma and IL8[original query] |
|---|
| Interleukin 10 haplotype associated with increased risk of hepatocellular carcinoma. Human molecular genetics 2003 Apr 12 (8): 901-6. Shin Hyoung Doo, Park Byung Lae, Kim Lyoung Hyo, Jung Ji Hyun, Kim Jun Yeon, Yoon Jung Hwan, Kim Yoon Jun, Lee Hyo-S |
| Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer. Carcinogenesis 2004 Feb 25 (2): 229-35. Campa Daniele, Zienolddiny Shanbeh, Maggini Valentina, Skaug Vidar, Haugen Aage, Canzian Federi |
| Variants of the IL8 and IL8RB genes and risk for gastric cardia adenocarcinoma and esophageal squamous cell carcinoma. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004 Dec 13 (12): 2251-7. Savage Sharon A, Abnet Christian C, Mark Steven D, Qiao You-Lin, Dong Zhi-Wei, Dawsey Sanford M, Taylor Philip R, Chanock Stephen |
| Association of common polymorphisms in inflammatory genes with risk of developing cancers of the upper aerodigestive tract. Cancer causes & control : CCC 2007 May 18 (4): 449-55. Campa Daniele, Hashibe Mia, Zaridze David, Szeszenia-Dabrowska Neonila, Mates Ioan Nicolae, Janout Vladimir, Holcatova Ivana, Fabiánová Eleonóra, Gaborieau Valérie, Hung Rayjean J, Boffetta Paolo, Brennan Paul, Canzian Federi |
| Polymorphisms in COX-2, NSAID use and risk of basal cell carcinoma in a prospective study of Danes. Mutation research 2007 Apr 617 (1-2): 138-46. Vogel Ulla, Christensen Jane, Wallin Håkan, Friis Søren, Nexø Bjørn A, Tjønneland An |
| The interleukin-8-251*T/*A polymorphism is not associated with risk for gastric carcinoma development in a Portuguese population. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2008 Feb 17 (1): 28-32. Canedo Paulo, Castanheira-Vale Abel J, Lunet Nuno, Pereira Fábio, Figueiredo Céu, Gioia-Patricola Lydie, Canzian Federico, Moreira Herculano, Suriano Gianpaolo, Barros Henrique, Carneiro Fátima, Seruca Raquel, Machado José |
| Association of polymorphisms in proinflammatory cytokine genes with the development of oral cancer in Southern Thailand. International journal of hygiene and environmental health 2010 Mar 213 (2): 146-52. Kietthubthew Suparp, Wickliffe Jeff, Sriplung Hutcha, Ishida Takafumi, Chonmaitree Tasnee, Au William |
| Pazopanib efficacy in renal cell carcinoma: evidence for predictive genetic markers in angiogenesis-related and exposure-related genes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Jun 29 (18): 2557-64. Xu Chun-Fang, Bing Nan X, Ball Howard A, Rajagopalan Dilip, Sternberg Cora N, Hutson Thomas E, de Souza Paul, Xue Zhengyu G, McCann Lauren, King Karen S, Ragone Leigh J, Whittaker John C, Spraggs Colin F, Cardon Lon R, Mooser Vincent E, Pandite Lini |
| Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective study. The Lancet. Oncology 2011 Nov 12 (12): 1143-50. Garcia-Donas Jesus, Esteban Emilio, Leandro-García Luis Javier, Castellano Daniel E, del Alba Aranzazu González, Climent Miguel Angel, Arranz José Angel, Gallardo Enrique, Puente Javier, Bellmunt Joaquim, Mellado Begoña, Martínez Esther, Moreno Fernando, Font Albert, Robledo Mercedes, Rodríguez-Antona Cristi |
| Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome. Cancer immunology research 2014 Apr 2 (4): 332-40. Charbonneau Bridget, Moysich Kirsten B, Kalli Kimberly R, Oberg Ann L, Vierkant Robert A, Fogarty Zachary C, Block Matthew S, Maurer Matthew J, Goergen Krista M, Fridley Brooke L, Cunningham Julie M, Rider David N, Preston Claudia, Hartmann Lynn C, Lawrenson Kate, Wang Chen, Tyrer Jonathan, Song Honglin, deFazio Anna, Johnatty Sharon E, Doherty Jennifer A, Phelan Catherine M, Sellers Thomas A, Ramirez Starr M, Vitonis Allison F, Terry Kathryn L, Van Den Berg David, Pike Malcolm C, Wu Anna H, Berchuck Andrew, Gentry-Maharaj Aleksandra, Ramus Susan J, Diergaarde Brenda, Shen Howard, Jensen Allan, Menkiszak Janusz, Cybulski Cezary, Lubi?ski Jan, Ziogas Argyrios, Rothstein Joseph H, McGuire Valerie, Sieh Weiva, Lester Jenny, Walsh Christine, Vergote Ignace, Lambrechts Sandrina, Despierre Evelyn, Garcia-Closas Montserrat, Yang Hannah, Brinton Louise A, Spiewankiewicz Beata, Rzepecka Iwona K, Dansonka-Mieszkowska Agnieszka, Seibold Petra, Rudolph Anja, Paddock Lisa E, Orlow Irene, Lundvall Lene, Olson Sara H, Hogdall Claus K, Schwaab Ira, du Bois Andreas, Harter Philipp, Flanagan James M, Brown Robert, Paul James, Ekici Arif B, Beckmann Matthias W, Hein Alexander, Eccles Diana, Lurie Galina, Hays Laura E, Bean Yukie T, Pejovic Tanja, Goodman Marc T, Campbell Ian, Fasching Peter A, Konecny Gottfried, Kaye Stanley B, Heitz Florian, Hogdall Estrid, Bandera Elisa V, Chang-Claude Jenny, Kupryjanczyk Jolanta, Wentzensen Nicolas, Lambrechts Diether, Karlan Beth Y, Whittemore Alice S, Culver Hoda Anton, Gronwald Jacek, Levine Douglas A, Kjaer Susanne K, Menon Usha, Schildkraut Joellen M, Pearce Celeste Leigh, Cramer Daniel W, Rossing Mary Anne, Chenevix-Trench Georgia, , , Pharoah Paul D P, Gayther Simon A, Ness Roberta B, Odunsi Kunle, Sucheston Lara E, Knutson Keith L, Goode Ellen |
| Phase II clinical and exploratory biomarker study of dacomitinib in patients with recurrent and/or metastatic squamous cell carcinoma of head and neck. Clinical cancer research : an official journal of the American Association for Cancer Research 2015 Feb 21 (3): 544-52. Kim Han Sang, Kwon Hyeong Ju, Jung Inkyung, Yun Mi Ran, Ahn Myung-Ju, Kang Byung Woog, Sun Jong-Mu, Kim Sung Bae, Yoon Dok-Hyun, Park Keon Uk, Lee Se-Hoon, Koh Yoon Woo, Kim Se Hun, Choi Eun Chang, Koo Dong Hoe, Sohn Jin Hee, Kim Bomi, Kwon Nak-Jung, Yun Hwan Jung, Lee Min Goo, Lee Ji Hyun, Kim Tae-Min, Kim Hye Ryun, Kim Joo Hang, Paik Soonmyung, Cho Byoung Ch |
| Association of interleukin-8 gene polymorphisms with the risk of hepatocellular carcinoma. Molecular biology reports 2014 Mar 41 (3): 1483-9. Wang Jun-li, Nong Le-gen, Wei Ye-sheng, Tang Yu-jin, Wang Jian-chu, Wang Chun-fa |
| Association of single nucleotide polymorphisms in IL8 and IL13 with sunitinib-induced toxicity in patients with metastatic renal cell carcinoma. European journal of clinical pharmacology 2015 Sep . Diekstra Meta H M, Liu Xiaoyan, Swen Jesse J, Boven Epie, Castellano Daniel, Gelderblom Hans, Mathijssen Ron H J, Rodríguez-Antona Cristina, García-Donas Jesus, Rini Brian I, Guchelaar Henk-J |
| IL8 polymorphisms and overall survival in pazopanib- or sunitinib-treated patients with renal cell carcinoma. British journal of cancer 2015 Mar 112 (7): 1190-8. Xu C-F, Johnson T, Garcia-Donas J, Choueiri T K, Sternberg C N, Davis I D, Bing N, Deen K C, Xue Z, McCann L, Esteban E, Whittaker J C, Spraggs C F, Rodríguez-Antona C, Pandite L N, Motzer R |
| Association of Interleukin-8 Gene Polymorphisms and Expression with Hepatocellular Carcinoma in Egyptian Patients with Liver Cirrhosis. The Egyptian journal of immunology 2017 Jan 24 (1): 143-152. Hassanin Omayma M, El-Masry Tarek M, El-Baz Ahmed, Adel-Abou-Zaghla Heba |
| Single nucleotide polymorphisms as prognostic and predictive biomarkers in renal cell carcinoma. Oncotarget 2017 Dec 8 (63): 106551-106564. Garrigós Carmen, Espinosa Marta, Salinas Ana, Osman Ignacio, Medina Rafael, Taron Miguel, Molina-Pinelo Sonia, Duran Ignac |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 01, 2023
- Content source: